Alisha M.Crovetto


Washington + 1.202.879.3791

Alisha Crovetto represents commercial clients in complex litigation ranging from government-challenged mergers to class actions and contract disputes. She has represented a number of clients in the health care industry, and her experience spans all stages of litigation from assessing potential claims and framing legal issues to conducting discovery, drafting and arguing dispositive motions, preparing for trial, and briefing appeals.

Alisha's recent matters include defending a biopharmaceutical company against antitrust claims relating to the enforcement of intellectual property rights and compliance with FDA regulations. She also has defended clients in merger litigation, including the FTC's challenge to the proposed combination of the Penn State Hershey Medical Center with Pinnacle Health Systems.

In addition, Alisha maintains an active pro bono practice that currently includes representing individuals asserting civil rights claims against more than three dozen defendants in federal district court.


  • Disabled man obtains settlement of more than $1 million in police brutality caseJones Day represented client M, a young man with cerebral palsy, and his grandmother in a Section 1983 matter against the D.C. Metropolitan Police Department, the Prince George's County Police Department, and many individual officers related to an excessive force case.
  • Sanofi defends proposed class action alleging improper Orange Book listings and sham patent litigationJones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that Sanofi improperly listed certain patents in the FDA's Orange Book and engaged in sham patent litigation to forestall competition for its diabetes drug, Lantus.
  • Parker Hannifin defends $4.3 billion acquisition of CLARCORFollowing a post-closing antitrust investigation, Parker Hannifin Corporation retained Jones Day to act as antitrust counsel in its litigation with the U.S. Department of Justice (DOJ) Antitrust Division over the company’s $4.3 billion acquisition of CLARCOR Inc.
  • Sanofi defends proposed class action alleging conspiracy to raise pricesJones Day is defending Sanofi-Aventis U.S. LLC against a proposed class action alleging that the company conspired with or through pharmacy benefit managers to raise prices for its diabetes drug, Lantus, in violation of federal and state antitrust, consumer protection, fraud, RICO, and employee benefit laws.
  • PinnacleHealth System and Penn State Hershey attempt to merge Pennsylvania hospitalsJones Day represented PinnacleHealth System and Penn State Milton S. Hershey Medical Center as antitrust counsel in the hospitals' proposed merger.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.